BREAKING--Infant Mortality Concern Emerges with Nirsevimab RSV Monoclonal Antibody Given to Newborns
By Peter A. McCullough, MD, MPH Respiratory syncytial virus (RSV) is a common viral infection affecting infants (~3.6 million) mainly under age 1 year easily treated with nebulizer therapy. Urgent care, emergency room, and hospitalization can occur for serious cases and if treated early, infant mortality should not be a concern. Among the 22.4 million […]
Discuss on Nostr!
Nostr Note ID note1pq6w833vjtlsgq7ed0y5mjulkeqj4e7876w5lup5h2v9mxzqeamqkvk06q Open on Primal.net Open on Snort.social Open on Iris.to Open on Coracle.social
New to Nostr?
Create an account now & join the conversation!
Promote it on DissentWatch!
- To advertise this post for $0.02 per visit send bitcoins to the address below
- The post will be promoted daily via social media & our "Featured News" display in multiple places
- You can add more anytime
- Ranking order in the Featured News box is based on the balance remaining
Received: 0 mBTC (0.00 USD)
Spent: 0 mBTC (0.00 USD)
Balance: 0 mBTC (0.00 USD)
The amounts above may be lagging behind. If you just sent a payment click below to get more up to date results and push the post to the "Featured News" box faster.